Cargando…

β-Thalassemia Intermedia: A Bird’s-Eye View

Beta-thalassemia is due to a defect in the synthesis of the beta-globin chains, leading to alpha/beta imbalance, ineffective erythropoiesis, and chronic anemia. The spectrum of thalassemias is wide, with one end comprising thalassemia minor, which consists of a mild hypochromic microcytic anemia wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Anthony, Tyan, Paul, Radwan, Amr, Mallat, Naji, Taher, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996637/
https://www.ncbi.nlm.nih.gov/pubmed/24764724
http://dx.doi.org/10.4274/Tjh.2014.0032
_version_ 1782313072465018880
author Haddad, Anthony
Tyan, Paul
Radwan, Amr
Mallat, Naji
Taher, Ali
author_facet Haddad, Anthony
Tyan, Paul
Radwan, Amr
Mallat, Naji
Taher, Ali
author_sort Haddad, Anthony
collection PubMed
description Beta-thalassemia is due to a defect in the synthesis of the beta-globin chains, leading to alpha/beta imbalance, ineffective erythropoiesis, and chronic anemia. The spectrum of thalassemias is wide, with one end comprising thalassemia minor, which consists of a mild hypochromic microcytic anemia with no obvious clinical manifestations, while on the other end is thalassemia major, characterized by patients who present in their first years of life with profound anemia and regular transfusion requirements for survival. Along the spectrum lies thalassemia intermedia, a term developed to describe patients with manifestations that are neither mild enough nor severe enough to be classified in the spectrum’s extremes. Over the past decade, our understanding of β-thalassemia intermedia has increased tremendously with regards to molecular information as well as pathophysiology. It is now clear that β-thalassemia intermedia has a clinical presentation as well as complications associated with the disease that are different from those of β-thalassemia major. This review is designed to tackle issues related to β-thalassemia intermedia from the basic definition of the disease to paramedical issues, namely the quality of life in these patients. Genetics and pathophysiology are revisited, as well as the complications specific to this disease. These complications include effects on several organ systems, including the cardiovascular, hepatic, endocrine, renal, brain, and skeletal systems. Extramedullary hematopoiesis is also discussed in this article. Risk factors are highlighted and cutoffs are identified to minimize morbidities in β-thalassemia intermedia. Several treatment modalities are considered by shining a light on the pros and cons of each modality, as well as the role of special pharmacological agents in the progress of the disease and its morbidities. Finally, health-related quality of life is discussed in these patients with a direct comparison to the more severe β-thalassemia major.
format Online
Article
Text
id pubmed-3996637
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-39966372014-04-24 β-Thalassemia Intermedia: A Bird’s-Eye View Haddad, Anthony Tyan, Paul Radwan, Amr Mallat, Naji Taher, Ali Turk J Haematol Review Beta-thalassemia is due to a defect in the synthesis of the beta-globin chains, leading to alpha/beta imbalance, ineffective erythropoiesis, and chronic anemia. The spectrum of thalassemias is wide, with one end comprising thalassemia minor, which consists of a mild hypochromic microcytic anemia with no obvious clinical manifestations, while on the other end is thalassemia major, characterized by patients who present in their first years of life with profound anemia and regular transfusion requirements for survival. Along the spectrum lies thalassemia intermedia, a term developed to describe patients with manifestations that are neither mild enough nor severe enough to be classified in the spectrum’s extremes. Over the past decade, our understanding of β-thalassemia intermedia has increased tremendously with regards to molecular information as well as pathophysiology. It is now clear that β-thalassemia intermedia has a clinical presentation as well as complications associated with the disease that are different from those of β-thalassemia major. This review is designed to tackle issues related to β-thalassemia intermedia from the basic definition of the disease to paramedical issues, namely the quality of life in these patients. Genetics and pathophysiology are revisited, as well as the complications specific to this disease. These complications include effects on several organ systems, including the cardiovascular, hepatic, endocrine, renal, brain, and skeletal systems. Extramedullary hematopoiesis is also discussed in this article. Risk factors are highlighted and cutoffs are identified to minimize morbidities in β-thalassemia intermedia. Several treatment modalities are considered by shining a light on the pros and cons of each modality, as well as the role of special pharmacological agents in the progress of the disease and its morbidities. Finally, health-related quality of life is discussed in these patients with a direct comparison to the more severe β-thalassemia major. Galenos Publishing 2014-03 2014-03-05 /pmc/articles/PMC3996637/ /pubmed/24764724 http://dx.doi.org/10.4274/Tjh.2014.0032 Text en © Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Haddad, Anthony
Tyan, Paul
Radwan, Amr
Mallat, Naji
Taher, Ali
β-Thalassemia Intermedia: A Bird’s-Eye View
title β-Thalassemia Intermedia: A Bird’s-Eye View
title_full β-Thalassemia Intermedia: A Bird’s-Eye View
title_fullStr β-Thalassemia Intermedia: A Bird’s-Eye View
title_full_unstemmed β-Thalassemia Intermedia: A Bird’s-Eye View
title_short β-Thalassemia Intermedia: A Bird’s-Eye View
title_sort β-thalassemia intermedia: a bird’s-eye view
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996637/
https://www.ncbi.nlm.nih.gov/pubmed/24764724
http://dx.doi.org/10.4274/Tjh.2014.0032
work_keys_str_mv AT haddadanthony bthalassemiaintermediaabirdseyeview
AT tyanpaul bthalassemiaintermediaabirdseyeview
AT radwanamr bthalassemiaintermediaabirdseyeview
AT mallatnaji bthalassemiaintermediaabirdseyeview
AT taherali bthalassemiaintermediaabirdseyeview